S-4.2, r. 23 - Regulation respecting the information that institutions must provide to the Minister of Health and Social Services

Schedule Disposition versions

2022-04-14

Schedule V.2

(s. 5.1.2)

1. The institution referred to in section 5.1.2 must provide the following information in respect of any user to whom it provided a first dialysis treatment:

(1)  concerning the user:

(a)  sex;

(b)  ethnic origin;

(c)  the postal code of the user’s residence;

(d)  the name of the municipality where the user’s residence is located;

(e)  the province where the user’s residence is located;

(2)  the date of the first consultation of the user with a physician who holds a specialist’s certificate in nephrology;

(3)  an indication that the user was followed in nephrology before the beginning of the follow-up in renal replacement and the place of the follow-up;

(4)  the user’s blood levels of albumin, serum bicarbonate, creatinine, calcium, hemoglobin, parathormone, phosphate and urea before the user’s first treatment;

(5)  the user’s height at the time of the first treatment;

(6)  the user’s weight in the month of the first treatment;

(7)  an indication that the user suffered a bilateral leg amputation, where applicable;

(8)  the user’s diagnosis of renal disease;

(9)  an indication of the user’s risk factors for renal disease and the nature of those factors, where applicable;

(10)  regarding the first administered renal replacement treatment:

(a)  date;

(b)  type;

(c)  the place where it was administered;

(d)  the level of help or care needed during its administration;

(e)  the type of access used;

(f)  an indication whether or not it was the long-term intended treatment for the user;

(g)  the reason for which the long-term intended treatment for the user could not be administered, where applicable;

(11)  concerning the long-term intended treatment for the user:

(a)  type;

(b)  the place where it should be administered;

(c)  the level of help or care needed during its administration.

2. The institution referred to in section 5.1.2 must provide the following information in respect of a user for whom it performs the monitoring of dialysis treatments:

(1)  concerning a user receiving any type of dialysis:

(a)  the postal code of the user’s residence;

(b)  regarding the user’s blood levels of albumin, calcium, creatinine, ferritin, hemoglobin, glycated hemoglobin, parathormone, phosphate, transferrin and urea:

i.  the laboratory results;

ii.  the date on which each test was conducted;

iii.  an indication of the tests that were not conducted, where applicable;

(c)  an indication that the user is registered on the waiting list for renal transplant, that the user is not waiting for renal transplant or that an evaluation is underway for the user to be registered on the waiting list;

(d)  if the user is under 18 years of age, the user’s height and the date of the measurement;

(2)  concerning a user receiving peritoneal dialysis treatments:

(a)  the user’s weight, the date on which the user was weighed and an indication that the user was weighed when the user was empty or full of fluid;

(b)  the weekly creatinine clearance and the date of its verification, where applicable;

(c)  the weekly measure of urea clearance (Kt/V) and the date of its verification, where applicable;

(d)  an indication that the weekly creatinine clearance or that the weekly measure of urea clearance is not carried out or is not done systematically, where applicable;

(3)  concerning a user receiving hemodialysis treatments:

(a)  the type of access used on the day on which the laboratory results were obtained;

(b)  the user’s weight before and after the treatment, and the date of weighing;

(c)  the weekly frequency of treatments and their duration.

3. The institution referred to in section 5.1.2 must provide the following information in respect of a user to whom it provides renal replacement services and that it transfers to a facility or whose treatment has changed or stopped:

(1)  concerning the last dialysis treatment administered to a user:

(a)  type;

(b)  the place where it was administered;

(c)  the level of help or care needed during its administration;

(d)  the number, on the institution’s permit, of the facility where it was administered;

(2)  concerning any transfer of a user to another facility:

(a)  date;

(b)  cause;

(c)  the number, on the institution’s permit, of the facility of destination;

(3)  concerning any change of treatment:

(a)  date;

(b)  cause;

(c)  regarding the new treatment administered:

i.  type;

ii.  the place where it was administered;

iii.  the level of help or care needed during its administration;

(d)  the number, on the institution’s permit, of the facility where it was administered;

(4)  if a user received a transplant, the transplanted organ;

(5)  in the case of treatment interruption, the date and cause of that interruption;

(6)  the date and cause of death of the user, where applicable.

4. In addition, upon any provision of information, the institution referred to in section 5.1.2 must provide the following information:

(1)  concerning the identity of the user:

(a)  name;

(b)  date of birth;

(c)  health insurance number;

(d)  the province or territory responsible for the health care insurance plan insuring the user;

(2)  the number, on the institution’s permit, of the transmitting facility.

O.C. 759-2019, s. 5; O.C. 317-2022, s. 6.

2019-08-01

Schedule V.2

(s. 5.1.2)

1. The institution referred to in section 5.1.2 must provide the following information in respect of any user to whom it provided a first dialysis treatment:

(1)  concerning the user:

(a)  sex;

(b)  ethnic origin;

(c)  the postal code of the user’s residence;

(d)  the name of the municipality where the user’s residence is located;

(e)  the province where the user’s residence is located;

(2)  the date of the first consultation of the user with a physician who holds a specialist’s certificate in nephrology;

(3)  an indication that the user was followed in nephrology before the beginning of the follow-up in renal replacement and the place of the follow-up;

(4)  the user’s blood levels of albumin, serum bicarbonate, creatinine, calcium, hemoglobin, parathormone, phosphate and urea before the user’s first treatment;

(5)  the user’s height at the time of the first treatment;

(6)  the user’s weight in the month of the first treatment;

(7)  an indication that the user suffered a bilateral leg amputation, where applicable;

(8)  the user’s diagnosis of renal disease;

(9)  an indication of the user’s risk factors for renal disease and the nature of those factors, where applicable;

(10)  regarding the first administered renal replacement treatment:

(a)  date;

(b)  type;

(c)  the place where it was administered;

(d)  the level of help or care needed during its administration;

(e)  the type of access used;

(f)  an indication whether or not it was the long-term intended treatment for the user;

(g)  the reason for which the long-term intended treatment for the user could not be administered, where applicable;

(11)  concerning the long-term intended treatment for the user:

(a)  type;

(b)  the place where it should be administered;

(c)  the level of help or care needed during its administration.

2. The institution referred to in section 5.1.2 must provide the following information in respect of a user for whom it performs the monitoring of dialysis treatments:

(1)  concerning a user receiving any type of dialysis:

(a)  the postal code of the user’s residence;

(b)  regarding the user’s blood levels of albumin, calcium, creatinine, ferritin, hemoglobin, glycated hemoglobin, parathormone, phosphate, transferrin and urea:

i.  the laboratory results;

ii.  the date on which each test was conducted;

iii.  an indication of the tests that were not conducted, where applicable;

(c)  an indication that the user is registered on the waiting list for renal transplant, that the user is not waiting for renal transplant or that an evaluation is underway for the user to be registered on the waiting list;

(d)  if the user is under 18 years of age, the user’s height and the date of the measurement;

(2)  concerning a user receiving peritoneal dialysis treatments:

(a)  the user’s weight, the date on which the user was weighed and an indication that the user was weighed when the user was empty or full of fluid;

(b)  the weekly creatinine clearance and the date of its verification, where applicable;

(c)  the weekly measure of urea clearance (Kt/V) and the date of its verification, where applicable;

(d)  an indication that the weekly creatinine clearance or that the weekly measure of urea clearance is not carried out or is not done systematically, where applicable;

(3)  concerning a user receiving hemodialysis treatments:

(a)  the type of access used on the day on which the laboratory results were obtained;

(b)  the user’s weight before and after the treatment, and the date of weighing;

(c)  the weekly frequency of treatments and their duration.

3. The institution referred to in section 5.1.2 must provide the following information in respect of a user to whom it provides renal replacement services and that it transfers to a facility or whose treatment has changed or stopped:

(1)  concerning the last dialysis treatment administered to a user:

(a)  type;

(b)  the place where it was administered;

(c)  the level of help or care needed during its administration;

(d)  the number, on the institution’s permit, of the facility where it was administered;

(2)  concerning any transfer of a user to another facility:

(a)  date;

(b)  cause;

(c)  the number, on the institution’s permit, of the facility of destination;

(3)  concerning any change of treatment:

(a)  date;

(b)  cause;

(c)  regarding the new treatment administered:

i.  type;

ii.  the place where it was administered;

iii.  the level of help or care needed during its administration;

(d)  the number, on the institution’s permit, of the facility where it was administered;

(4)  if a user received a transplant, the transplanted organ;

(5)  in the case of treatment interruption, the date and cause of that interruption;

(6)  the date and cause of death of the user, where applicable.

4. In addition, upon any provision of information, the institution referred to in section 5.1.2 must provide the following information:

(1)  concerning the identity of the user:

(a)  name;

(b)  date of birth;

(c)  health insurance number;

(d)  the province or territory responsible for the provincial health care insurance plan insuring the user;

(2)  the number, on the institution’s permit, of the transmitting facility.

O.C. 759-2019, s. 5.